A A A

Blogs


Dr. Steve Silberberg's picture

Blue eyed people have 1 common ancestor

By Dr. Steve Silberberg - Posted on 23 May 2013

http://www.sciencedaily.com/releases/2008/01/080130170343.htm
New research shows that people with blue eyes have a single, common ancestor. A team at the University of Copenhagen have tracked down a genetic mutation which took place 6-10,000 years ago and is the cause of the eye colour of all blue-eyed humans alive on the planet today.

Dr. Adam D. Mark's picture

Healthy Food for the eyes

By Dr. Adam D. Mark - Posted on 17 May 2013

Five Foods May Help With Retaining Good Vision.

The Huffington Post (5/16)....

Dr. Adam D. Mark's picture

Video games and "lazy eye"

By Dr. Adam D. Mark - Posted on 23 April 2013

Study: Tetris Video Game May Help Treat Lazy Eye.

BBC News (4/23, Roberts) reports,
"Canadian doctors say they have found an inventive way to treat lazy eye - playing the Tetris video game." In a study published in the journal Current Biology, researchers from McGill University "discovered the popular tile-matching puzzle could train both eyes to work together." In the study of 18 adults, Tetris "worked better than conventional patching of the good eye to make the weak one work harder."

Dr. Steve Silberberg's picture

Cholesterol - lowering eye drops may cure leading cause of elderly blindness

By Dr. Steve Silberberg - Posted on 04 April 2013

Cholesterol - lowering eye drops may cure leading cause of elderly blindness

ISTOCKPHOTO
2 Comments
/ Shares/ Tweets/Stumble/EmailMore +
The leading cause of blindness in older American adults may have met its match.

A new study finds cholesterol-lowering drugs given in the form of eye drops cured macular degeneration in mice, fueling hopes the same treatment may work for humans.

14 PHOTOS
12 scary things your eyes say about your health

Dr. Steve Silberberg's picture

Could this be the magic bullet?

By Dr. Steve Silberberg - Posted on 28 March 2013

http://www.nypost.com/p/news/international/every_cancer_kills_tumor_them...

Researchers might have found the Holy Grail in the war against cancer, a miracle drug that has killed every kind of cancer tumor it has come in contact with.

The drug works by blocking a protein called CD47 that is essentially a "do not eat" signal to the body's immune system, according to Science Magazine.

Dr. Steve Silberberg's picture

Red wine dark chocolate..Live to 150

By Dr. Steve Silberberg - Posted on 11 March 2013

Scientist: Synthetic Resveratrol May Help People Live To 150.

Dr. Steve Silberberg's picture

FDA approves first artificial retina

By Dr. Steve Silberberg - Posted on 15 February 2013

FDA Approves Device For Patients With Retinitis Pigmentosa.
The Food and Drug Administration's approval of a new device for patients with retinitis pigmentosa (RP) received heavy coverage in print and online, and was featured on two of last night's national news broadcasts. Most articles quote one or more FDA officials, and many point out that the National Eye Institute partially funded research on the device. Many sources also point to the innovative nature of the device and the potential benefits the device may hold for individuals with RP.

Dr. Adam D. Mark's picture

MYOPIA in the news

By Dr. Adam D. Mark - Posted on 12 February 2013

Reuters (2/12, Doyle)
reports that according to a study published online Feb. 4 in the journal Ophthalmology, myopia appeared to worsen in children during the winter months when days are at their shortest. Conversely, the progression of myopia was far less during the summer months with longer days. Researchers arrived at this conclusion after studying 200 eight- to 14-year-old youngsters from Denmark, a country where daylight can vary from as little as seven hours per day in winter to as much as nearly 18 hours per day during mid-summer.

Dr. Steve Silberberg's picture

BIonic eye available soon!!

By Dr. Steve Silberberg - Posted on 29 January 2013

Bionic Eye May Soon Be Available In US.
The Wall Street Journal (1/29, D1, Wang, Subscription Publication, 2.29M) reports on a new technology, known as Argus II, that may soon be available in the US, which combines an eye implant and video-camera-enabled glasses. The retinal prosthesis is awaiting approval by the Food and Drug Administration, and will most likely benefit patients with retinitis pigmentosa, as well as those with severe macular degeneration, which, according to the National Eye Institute, is an age-related disease that damages the part of the eye that perceives fine detail.

Doctor Silberberg

Dr. Steve Silberberg

Founder
An Eye to the Future
more about Dr. Silberberg

Doctor Mark

Dr. Adam Mark

Partner
An Eye to the Future
more about Dr. Mark

Subscribe to our RSS Feed

Syndicate content